[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341723-105":59,"doc-detail-341723-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","angptl4-suppresses-clear-cell-renal-cell-carcinoma-via-inhibition-of-lysosomal-acid-lipase","ANGPTL4 Suppresses Clear Cell Renal Cell Carcinoma via Inhibition of Lysosomal Acid Lipase","","Clear cell renal cell carcinoma (ccRCC) is a dominant, aggressive kidney cancer subtype, yet most tumors show elevated angiopoietin-like 4 (ANGPTL4) while a clinically relevant subset does not. ANGPTL4-low patients exhibit worse prognosis and distinct biology: higher frequency of wild-type VHL and enrichment of lipid metabolism genes. Using RCC tumor models with WT VHL, ANGPTL4 is demonstrated as a tumor suppressor, with ANGPTL4 loss increasing lysosomal acid lipase (LAL)-dependent growth and colony formation, rescued by N-terminal ANGPTL4 expression. Mechanistically, ANGPTL4 loss elevates LAL activity, suggesting LAL regulation drives tumor suppression and may guide therapies targeting lipid reliance in these patients.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/angptl4-suppresses-clear-cell-renal-cell-carcinoma-via-inhibition-of-lysosomal-acid-lipase/341723/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/angptl4-suppresses-clear-cell-renal-cell-carcinoma-via-inhibition-of-lysosomal-acid-lipase/341723.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What clinical pattern distinguishes ANGPTL4-low ccRCC patients?","Question",{"text":113,"@type":114},"A subset of patients shows no increase in ANGPTL4 expression, and these ANGPTL4-low cancers have a worse prognosis than tumors with high ANGPTL4.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does ANGPTL4 affect ccRCC tumor behavior in the reported study?",{"text":118,"@type":114},"The study demonstrates that ANGPTL4 functions as a tumor suppressor: loss of ANGPTL4 increases tumor growth and colony formation in a lysosomal acid lipase (LAL)-dependent manner.",{"name":120,"@type":111,"acceptedAnswer":121},"What mechanism links ANGPTL4 to lipid metabolism and potential therapy targets?",{"text":122,"@type":114},"The loss of ANGPTL4 increases LAL activity in ccRCC cells, and ANGPTL4-low patient tumors show enrichment of lipid metabolism programs, suggesting increased reliance on lipid metabolism as a future therapeutic target.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341723,1790198657,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-24-0016](https://doi.org/10.1158/2767-9764.CRC-24-0016)  OPEN ACCESS  \nANGPTL4 Suppresses Clear Cell Renal Cell Carcinoma via Inhibition of Lysosomal Acid Lipase  \nZeng Jin1,2, Umasankar De2, Tanzia Islam Tithi1,2, Jeremy Kleberg3, Akhila Nataraj4, Elena Jolley5, Madison E. Carelock1,2, Brandon S. Davies6, Weizhou Zhang2,7, and Ryan Kolb2,7  \n􀀶  \nABSTRACT  \nRenal cell carcinoma (RCC), the most common form of kidney cancer, is a heterogeneous disease with clear cell RCC (ccRCC) being the most prevalent and aggressive subtype. While most ccRCC tumors have elevated expression of angiopoietin-like 4 (ANGPTL4), in our study we identified a significant subset of patients whose cancers show no increase in ANGPTL4 expression. These patients have a worse prognosis compared to the patients with high expression of ANGPTL4 . These ANGPTL4-low cancers are characterized by the increased frequency of wild-type Von Hippel-Lindau (WT VHL), a gene that is commonly mutated in ccRCC, and an enrichment for genes associated with lipid metabolism. Using RCC tumor models with WT VHL, we demonstrate that ANGPTL4 behaves as a tumor suppressor. The loss of ANGPTL4 in ccRCC cell lines results in increased tumor growth and colony  \nformation in a lysosomal acid lipase (LAL)-dependent manner, a phenotype rescued by the expression of N-terminus ANGPTL4 . At the mechanistic level, the loss of ANGPTL4 increases LAL activity inccRCC cells. These data suggest that ANGPTL4 enacts its tumorsuppressive effects in ccRCC by regulating LAL activity. Importantly, the identified patient cohort with low ANGPTL4 expression may exhibit increased reliance on lipid metabolism, which can be a point of target for future therapy.  \nSignificance: Our data indicate angiopoietin-like 4 (ANGPTL4) acts as a tumor suppressor in clear cell renal cell carcinoma via regulating lipid metabolism and identifies a cohort of patients with lower expression of ANGPTL4 that are correlated with shorter survival.  \nIntroduction  \nRenal cell carcinomas (RCC) account for about 76,000 new cancer cases annually in the U.S. and 403,000 cases worldwide ( 1, 2) . Clear cell RCC (ccRCC) is the most common and aggressive subtype, accounting for 75% to 85% of cases with a 5-year survival rate of 50% to 69% for all cases and only  \n1Cancer Biology Concentration, Biomedical Graduate Program, College of Medicine, University of Florida, Gainesville, Florida. 2Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, Florida. 3Department of Biochemistry and Molecular Biology, College of Liberal Arts and Sciences, University of Florida, Gainesville, Florida. 4Department of Health Science, College of Public Health and Health Professions, University of Florida, Gainesville, Florida. 5Interdisciplinary Medical Sciences Division, Florida State University, Tallahassee, Florida. 6Department of Biochemistry and Molecular Biology, Fraternal Order of Eagles Diabetes Research Center, and Obesity Research and Education Initiative, University of Iowa, Iowa City, Iowa. 7UF Health Cancer Center, University of Florida, Gainesville, Florida.  \nCorresponding Author: Ryan Kolb, Department of Pathology, Immunology and Laboratory medicine, University of Florida, 1395 Center Drive D6-33D, Post Box 100275, Gainseville, [FL 32610. E-mail:](FL 32610. E-mail: ryankolb@ufl.edu)[ ryankolb@ufl.edu](FL 32610. E-mail: ryankolb@ufl.edu)  \n[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-24-0016  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4. 0) license.  \n©2024 The Authors; Published by the American Association for Cancer Research  \n10% for metastatic disease (3) . ccRCC is characterized by the accumulation of lipid droplets in cancer cells giving them the characteristic “clear” cytoplasm under histological observation (2) . The increas","cbCaidUqHWorVRWO","https://ap.wps.com/l/cbCaidUqHWorVRWO","pdf",7176424,13,"English","# Abstract\n## Significance\n# Introduction","[{\"question\":\"What clinical pattern distinguishes ANGPTL4-low ccRCC patients?\",\"answer\":\"A subset of patients shows no increase in ANGPTL4 expression, and these ANGPTL4-low cancers have a worse prognosis than tumors with high ANGPTL4.\"},{\"question\":\"How does ANGPTL4 affect ccRCC tumor behavior in the reported study?\",\"answer\":\"The study demonstrates that ANGPTL4 functions as a tumor suppressor: loss of ANGPTL4 increases tumor growth and colony formation in a lysosomal acid lipase (LAL)-dependent manner.\"},{\"question\":\"What mechanism links ANGPTL4 to lipid metabolism and potential therapy targets?\",\"answer\":\"The loss of ANGPTL4 increases LAL activity in ccRCC cells, and ANGPTL4-low patient tumors show enrichment of lipid metabolism programs, suggesting increased reliance on lipid metabolism as a future therapeutic target.\"}]","ANGPTL4 Suppresses Clear Cell Renal Cell Carcinoma via Inhibition of Lysosomal Acid Lipase | PDF",1790043362,33,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f4987f601e2538c0c99fb5bb13e7f0.webp",983,1263,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4fe2ed81b46f2fe57a03fc6f7b98c31.webp",982,1262,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6632c33ca709bfa35f31c3d01b9b6d91.webp",981,1261,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba3fec41f1b07da3ec2d626af40436a8.webp",980,1259]